Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A single centre pilot study to assess assess the safety and efficacy of cangrelor plus aspirin in neurointervention for platelet inhibition in patients who require acute stenting in the setting of ischemic stroke.

Next Previous
X
Search
Trial Profile

A single centre pilot study to assess assess the safety and efficacy of cangrelor plus aspirin in neurointervention for platelet inhibition in patients who require acute stenting in the setting of ischemic stroke.

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Mar 2019

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cangrelor (Primary) ; Aspirin
  • Indications Coronary artery disease
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 15 Mar 2019 New trial record
    • 08 Feb 2019 Results (n=6, enrolled between Oct 2017 to Jul 2018) presented at the International Stroke Conference 2019

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top